Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedJul 04, 2026
DataAggregated Company Financials
Companies9
  • 7D1.8%
  • 3M16.0%
  • 1Y-11.5%
  • YTDn/a

The Clinical Research and Equipment industry is up 1.9% in the last week, with MedCap up 6.2%. In the past year, the industry is down 11%. As for the next few years, earnings are expected to grow by 17% per annum.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 04 Jul 2026SEK 31.8bSEK 14.6b-SEK 871,304,353.0036.5x-36.5x2.2x
Mon, 01 Jun 2026SEK 29.0bSEK 14.6b-SEK 870,015,077.0034x-33.3x2x
Wed, 29 Apr 2026SEK 28.4bSEK 14.6b-SEK 970,997,077.0032.9x-29.3x1.9x
Fri, 27 Mar 2026SEK 26.6bSEK 14.6b-SEK 838,374,077.0032x-31.7x1.8x
Sun, 22 Feb 2026SEK 27.7bSEK 14.6b-SEK 878,801,427.0033x-31.5x1.9x
Tue, 20 Jan 2026SEK 29.0bSEK 14.9b-SEK 744,515,427.0045.1x-38.9x1.9x
Thu, 18 Dec 2025SEK 32.0bSEK 14.9b-SEK 744,515,427.0053.2x-43x2.2x
Sat, 15 Nov 2025SEK 34.2bSEK 14.8b-SEK 709,926,012.0057.4x-48.2x2.3x
Mon, 13 Oct 2025SEK 34.6bSEK 14.7bSEK 61.3m51.5x564.4x2.4x
Wed, 10 Sep 2025SEK 35.7bSEK 14.7bSEK 60.9m56.9x586x2.4x
Fri, 08 Aug 2025SEK 35.4bSEK 14.8bSEK 158.0m60x223.9x2.4x
Sun, 06 Jul 2025SEK 47.1bSEK 16.6bSEK 416.3m71.6x113.2x2.8x
Tue, 03 Jun 2025SEK 45.6bSEK 16.6bSEK 404.2m70.5x112.9x2.7x
Thu, 01 May 2025SEK 45.3bSEK 16.6bSEK 422.0m44.2x107.4x2.7x
Sat, 29 Mar 2025SEK 35.8bSEK 16.6bSEK 609.4m37.2x58.7x2.1x
Mon, 24 Feb 2025SEK 41.8bSEK 16.6bSEK 615.4m41.4x67.9x2.5x
Wed, 22 Jan 2025SEK 39.2bSEK 16.7b-SEK 1,152,911,426.0042.6x-34x2.3x
Fri, 20 Dec 2024SEK 42.9bSEK 16.7b-SEK 1,152,911,426.0049.6x-37.2x2.6x
Sun, 17 Nov 2024SEK 41.8bSEK 16.8b-SEK 948,072,426.0047x-44.1x2.5x
Tue, 15 Oct 2024SEK 47.1bSEK 16.7b-SEK 988,175,491.0058.4x-47.7x2.8x
Thu, 12 Sep 2024SEK 47.6bSEK 16.7b-SEK 988,175,491.0058.6x-48.2x2.9x
Sat, 10 Aug 2024SEK 48.0bSEK 16.7b-SEK 1,128,120,510.0060.1x-42.5x2.9x
Mon, 08 Jul 2024SEK 43.8bSEK 16.3b-SEK 1,188,686,510.0057x-36.8x2.7x
Wed, 05 Jun 2024SEK 42.4bSEK 16.3b-SEK 1,188,686,510.0059.3x-35.7x2.6x
Fri, 03 May 2024SEK 38.1bSEK 16.2b-SEK 1,241,845,705.0036.7x-30.7x2.3x
Sun, 31 Mar 2024SEK 40.6bSEK 16.0b-SEK 1,122,792,210.0035.6x-36.2x2.5x
Tue, 27 Feb 2024SEK 38.4bSEK 16.0b-SEK 1,122,868,210.0041.9x-34.2x2.4x
Thu, 25 Jan 2024SEK 36.9bSEK 15.5b-SEK 1,393,723,683.0045.1x-26.5x2.4x
Sat, 23 Dec 2023SEK 37.2bSEK 15.5b-SEK 1,393,723,683.0044.5x-26.7x2.4x
Mon, 20 Nov 2023SEK 33.1bSEK 15.4b-SEK 1,398,076,683.0035.5x-23.6x2.1x
Wed, 18 Oct 2023SEK 23.8bSEK 15.1b-SEK 1,134,516,711.0033.1x-21x1.6x
Fri, 15 Sep 2023SEK 27.9bSEK 15.1b-SEK 1,133,713,072.0038.8x-24.6x1.9x
Sun, 13 Aug 2023SEK 31.7bSEK 15.1b-SEK 213,871,038.0046.2x-148.2x2.1x
Tue, 11 Jul 2023SEK 35.4bSEK 14.6b-SEK 172,476,038.0038x-205.5x2.4x
Price to Earnings Ratio

-205.5x


Total Market Cap: SEK 35.4bTotal Earnings: -SEK 172,476,038.00Total Revenue: SEK 14.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average 23x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swedish Life Sciences Tools and Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 2.4x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market3.36%
Healthcare4.92%
Life Sciences1.84%
Clinical Research and Equipment1.84%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MCAP MedCapSEK 545.006.2%
+SEK 480.6m		12.1%PE36.3x
GENO Genovis AB (publ.)SEK 20.455.1%
+SEK 65.4m		-29.0%PE55.6x
BICO BICO GroupSEK 16.462.4%
+SEK 26.8m		-55.2%PS0.8x
ALIF B AddLifeSEK 170.100.06%
+SEK 12.2m		-9.1%PE36.5x

Latest News

MAGLE
SEK 1.00
Magle Chemoswed Holding
7D
-1.0%
1Y
-96.3%
MCAP
SEK 545.00
MedCap
7D
6.2%
1Y
12.1%
Analysis Article • Jun 30

MedCap (STO:MCAP) Ticks All The Boxes When It Comes To Earnings Growth

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
BICO
SEK 16.46
BICO Group
7D
2.4%
1Y
-55.2%
Narrative Update • Jun 26

BICO: Long Term Incentive Plan Will Support Future Shareholder Return

Analysts have reduced their price target for BICO Group to SEK 23 from SEK 30, citing updated assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. What's in the News for BICO Group BICO Group's Annual General Meeting on May 7, 2026 approved the implementation of a share based long term incentive program for 2026 to 2029, directed at the CEO, group management, and key employees.
IDLDX
SEK 0.41
IDL Diagnostics
7D
-3.1%
1Y
-18.1%
ALIF B
SEK 170.10
AddLife
7D
0.06%
1Y
-9.1%
PRO
SEK 10.00
Promimic
7D
-2.9%
1Y
-41.0%
LEVBIO
SEK 0.25
Level Bio
7D
-11.3%
1Y
-16.0%
GENO
SEK 20.45
Genovis AB (publ.)
7D
5.1%
1Y
-29.0%
Analysis Article • May 01

Genovis AB (publ.) Just Missed Earnings - But Analysts Have Updated Their Models

Genovis AB (publ.) ( STO:GENO ) shareholders are probably feeling a little disappointed, since its shares fell 4.4% to...
PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%